Publication 2024
428.
Mina IK, Iglesias-Martinez LF, Ley M, Fillinger L, Perco P, Siwy J, Mischak H, Jankowski V.
Investigation of the Urinary Peptidome to Unravel Collagen Degradation in Health and Kidney Disease.
Proteomics. 2024 Dec 30:e202400279. doi: 10.1002/pmic.202400279. Online ahead of print.
427.
An DW, Martens DS, Mokwatsi GG, Yu YL, Chori BS, Latosinska A, Isiguzo G, Eder S, Zhang DY, Mayer G, Kruger R, Brguljan-Hitij J, Delles C, Mels CMC, Stolarz-Skrzypek K, Rajzer M, Verhamme P, Schutte AE, Nawrot TS, Li Y, Mischak H, Odili AN, Staessen JA.
Urinary Proteomics and Systems Biology Link Eight Proteins to the Higher Risk of Hypertension and Related Complications in Blacks Versus Whites.
Proteomics. 2024 Nov 24:e202400207. doi: 10.1002/pmic.202400207. Online ahead of print.
426.
Yu YL, An DW, Chori BS, Kaleta BP, Mokwatsi G, Martens DS, Abiodun OO, Anya T, Łebek-Szatańska A, Yeh JS, Mels CMC, Latosinska A, Kruger R, Isiguzo G, Narkiewicz K, Shehu MN, Salazar M, Espeche W, Mujaj B, Brgulian-Hitij J, Olszanecka A, Wojciechowska W, Reyskens P, Rajzer M, Januszewicz A, Stolarz-Skrzypek K, Asayama K, Allegaert K, Verhamme P, Mischak H, Nawrot TS, Odili AN, Staessen JA; UPRIGHT-HTM investigators.
Racial and regional disparities in the risk of noncommunicable disease between sub-Saharan black and European white patients.
J Hypertens. 2024 Nov 22. doi: 10.1097/HJH.0000000000003930. Online ahead of print.
425.
Frantzi M, Morillo AC, Lendinez G, Blanca A, Lopez Ruiz D, Parada J, Heidegger I, Culig Z, Mavrogeorgis E, Beltran AL, Mora-Ortiz M, Carrasco-Valiente J, Mischak H, Medina RA, Campos Hernandez P, Gómez Gómez E.
Validation of a Urine-Based Proteomics Test to Predict Clinically Significant Prostate Cancer: Complementing mpMRI Pathway.
Pathobiology. 2024 Nov 11:1-10. doi: 10.1159/000542465. Online ahead of print.
424.
Latosinska A, Frantzi M, Siwy J.
Peptides as "better biomarkers"? Value, challenges, and potential solutions to facilitate implementation.
Mass Spectrom Rev. 2024 Nov-Dec;43(6):1195-1236. doi: 10.1002/mas.21854. Epub 2023 Jun 26.
423.
An DW, Yu YL, Martens DS, Latosinska A, Zhang ZY, Mischak H, Nawrot TS, Staessen JA.
Statistical approaches applicable in managing OMICS data: Urinary proteomics as exemplary case.
Mass Spectrom Rev. 2024 Nov-Dec;43(6):1237-1254. doi: 10.1002/mas.21849. Epub 2023 May 4.
422.
Yu YL, Siwy J, An DW, González A, Hansen T, Latosinska A, Pellicori P, Ravassa S, Mariottoni B, Verdonschot JA, Ahmed F, Petutschnigg J, Rossignol P, Heymans S, Cuthbert JJ, Girerd N, Clark AL, Verhamme P, Nawrot TS, Janssens S, Cleland JG, Zannad F, Diez J, Mischak H, Ferreira JP, Staessen JA; HOMAGE investigators.
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.
Heart. 2024 Sep 16;110(19):1180-1187. doi: 10.1136/heartjnl-2023-323796.
421.
Siwy J, Keller F, Banasik M, Peters B, Dudoignon E, Mebazaa A, Gülmez D, Spasovski G, Salgueira Lazo M, Rajzer MW, Fuławka L, Dzitkowska-Zabielska M, Mischak H, Hecking M, Beige J, Wendt R, and UriCoV Working Group.
Mortality Risk and Urinary Proteome Changes in Acute COVID-19 Survivors in the Multinational CRIT-COV-U Study
Biomedicines 2024 Sep 13;12(9):2090. doi: 10.3390/biomedicines12092090.
420.
Yu YL, Martens DS, An DW, Chori B, Latosinska A, Siwy J, Odili AN, Stolarz-Skrzypek K, Maestre GE, Asayama K, Li Y, Verhamme P, Allegaert K, Mischak H, Nawrot TS, Staessen JA.
Osteoporosis in Relation to a Bone-Related Aging Biomarker Derived from the Urinary Proteomic Profile: A Population Study
Aging Dis. 2024, Jul 29. doi: 10.14336/AD.2024.0303. Online ahead of print.
419.
Frattini T, Devos H, Makridakis M, Roubelakis MG, Latosinka A, Mischak H, Schanstra JP, Vlahou A, Saulnier-Blache JS.
Benefits and limits of decellularization on mass-spectrometry-based extracellular matrix proteome analysis of mouse kidney
Proteomics. 2024, Jun 19:e2400052. Epub ahead of print
418.
Heidegger I, Frantzi M, Salcher S, Tymoszuk P, Martowicz A, Gomez-Gomez E, Blanca A, Lendinez Cano G, Latosinska A, Mischak H, Vlahou A, Langer C, Aigner F, Puhr M, Krogsdam A, Trajanoski Z, Wolf D, Pircher A.
Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature
Eur Urol Oncol. 2024, S2588-9311(24)00144-5. Epub 2024 Jun 7.
417.
Latosinska A, Siwy J, Mischak H.
Multiomics: paving the path towards personalized prevention of hypertension
J Hypertens. 2024, 42(6):962-964. Epub 2024 May 1.
416.
Yu YL, Siwy J, An DW, González A, Hansen T, Latosinska A, Pellicori P, Ravassa S, Mariottoni B, Verdonschot JA, Ahmed F, Petutschnigg J, Rossignol P, Heymans S, Cuthbert JJ, Girerd N, Clark AL, Verhamme P, Nawrot TS, Janssens S, Cleland JG, Zannad F, Diez J, Mischak H, Ferreira JP, Staessen JA; HOMAGE investigators.
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
Heart. 2024, 110(19):1180-1187. Epub 2024 May 9.
415.
Lauder L, Siwy J, Mavrogeorgis E, Keller F, Kunz M, Wachter A, Emrich IE, Böhm M, Mischak H, Mahfoud F.
Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in Hypertension
Hypertension. 2024, 81(6):1374-1382. Epub 2024 Apr 4.
414.
Mavrogeorgis E, Kondyli M, Mischak H, Vlahou A, Siwy J, Rossing P, Campbell A, Mels CMC, Delles C, Staessen JA, Latosinska A, Persu A.
Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiology
J Hypertens. 2024, 42(8):1331-1339. Epub 2024 Mar 28.
413.
Faguer S, Piedrafita A, Sanz AB, Siwy J, Mina IK, Alves M, Bousquet P, Marcheix B, Casemayou A, Klein J, Minville V, Breuil B, Ortiz A, Schanstra JP.
Performances of acute kidney injury biomarkers vary according to sex
Clin Kidney J. 2024, 17(5):sfae091.
412.
Lumi R, Petri S, Siwy J, Latosinska A, Raad J, Zürbig P, Skripuletz T, Mischak H, Beige J.
Small peptide CSF fingerprint of amyotrophic lateral sclerosis
PLoS One. 2024, 19(4):e0302280.
411.
Jaimes Campos MA, Mavrogeorgis E, Latosinska A, Eder S, Buchwinkler L, Mischak H, Siwy J, Rossing P, Mayer G, Jankowski J.
Urinary peptide analysis to predict the response to blood pressure medication
Nephrol Dial Transplant. 2024, 39(5):873-883. Epub 2023 Oct 31.
410.
Mavrogeorgis E, Valkenburg S, Siwy J, Latosinska A, Glorieux G, Mischak H, Jankowski J.
Integration of Urinary Peptidome and Fecal Microbiome to Explore Patient Clustering in Chronic Kidney Disease
Proteomes 2024, 12(2):11.
409.
Rupprecht H, Catanese L, Amann K, Hengel FE, Huber TB, Latosinska A, Lindenmeyer MT, Mischak H, Siwy J, Wendt R, Beige J.
Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers
Int J Mol Sci. 2024, 25(7):3678.
408.
Catanese L, Rupprecht H, Huber TB, Lindenmeyer MT, Hengel FE, Amann K, Wendt R, Siwy J, Mischak H, Beige J.
Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review
Int J Mol Sci. 2024, 25(6):3519.
407.
Mina IK, Mavrogeorgis E, Siwy J, Stojanov R, Mischak H, Latosinska A, Jankowski V.
Multiple urinary peptides display distinct sex-specific distribution
Proteomics. 2024 Mar;24(5):e2300227. Epub 2023 Sep 26.
406.
Mavrogeorgis E, He T, Mischak H, Latosinska A, Vlahou A, Schanstra JP, Catanese L, Amann K, Huber TB, Beige J, Rupprecht H, Siwy J.
Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease
Nephrol Dial Transplant. 2024, 39(3):453-462. Epub 2023 Sep 11.
405.
Yu YL, Huang QF, An DW, Raad J, Martens DS, Latosinska A, Stolarz-Skrzypek K, Van Cleemput J, Feng YQ, Mischak H, Allegaert K, Verhamme P, Janssens S, Nawrot TS, Staessen JA.
OSTEO18, a novel urinary proteomic signature, associated with osteoporosis in heart transplant recipients
Heliyon. 2024, 10(2):e24867.
404.
Brasseler M, Mischak H, Schanstra JP, Michel JM, Pape L, Felderhoff-Müser U.
Gestational Age-Related Urinary Peptidome Changes in Preterm and Term Born Infants
Neonatology. 2024, 121(3):305-313. Epub 2024 Feb 21.